Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.43 |
| ▸ | GCK | P35557 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.40 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL202626 | 0.89 | KDM4E (0.57) | KDM4EPOLBRAB9ANPC1MTNR1B | |
| SCHEMBL204354 | 0.89 | L3MBTL1 (0.44) | L3MBTL1TDP1KDM4EPOLBRAB9A | |
| SCHEMBL203718 | 0.86 | CTNNB1 (0.54) | L3MBTL1TDP1KDM4ERAB9ANPSR1 | |
| SCHEMBL203989 | 0.85 | KDM4E (0.44) | KDM4EPOLBRAB9AMTNR1BNPSR1 | |
| SCHEMBL203538 | 0.84 | LMNA (0.51) | L3MBTL1TDP1KDM4EPOLBRAB9A | |
| SCHEMBL9155384 | 0.84 | SIRT2 (0.47) | KDM4EPOLBRAB9ANPC1MTNR1B | |
| SCHEMBL8584984 | 0.84 | GCK (0.45) | L3MBTL1TDP1KDM4EGCK | |
| SCHEMBL7758309 | 0.83 | KDR (0.39) | NPC1GCKLMNAMEN1KMT2A | |
| SCHEMBL203517 | 0.83 | KDR (0.39) | NPC1GCKLMNAMEN1KMT2A | |
| SCHEMBL8603089 | 0.83 | LMNA (0.47) | L3MBTL1TDP1KDM4EPOLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12464971-B2 | Sowing device and method for treating seeds during planting | SYNGENTA CROP PROTECTION AG (CH) | 2025-11-11 | — | — | US | disclosed |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2025-07-31 | — | — | US | disclosed |
| US-11185074-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-11-30 | — | — | US | disclosed |
| US-20150144027-A1 | PARTICULATE WOOD PRESERVATIVE AND METHOD FOR PRODUCING THE SAME | KOPPERS INC. (F/K/A KOPPERS INDUSTRIES, INC.) | 2015-05-28 | — | — | US | disclosed |
| US-8871277-B2 | Particulate wood preservative and method for producing the same | OSMOSE, INC. (US) | 2014-10-28 | — | — | US | disclosed |
| US-20130324457-A1 | 1-ARYL-5-ALKYL PYRAZOLE DERIVATIVE COMPOUNDS, PROCESSES OF MAKING AND METHODS OF USING THEREOF | AVENTIS AGRICULTURE (FR) | 2013-12-05 | — | — | US | disclosed |
| US-20130230575-A1 | PARTICULATE WOOD PRESERVATIVE AND METHOD FOR PRODUCING THE SAME | OSMOSE, INC. (US) | 2013-09-05 | — | — | US | disclosed |
| US-8445519-B2 | 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof | AVENTIS AGRICULTURE (FR) | 2013-05-21 | — | — | US | disclosed |
| US-8409627-B2 | Particulate wood preservative and method for producing the same | OSMOSE, INC. (US) | 2013-04-02 | — | — | US | disclosed |
| US-8088801-B2 | Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof | MERIAL LIMITED (US) | 2012-01-03 | — | — | US | disclosed |
| EP-0915885-A1 | PYRAZINE DERIVATIVES AND THEIR USE FOR MATERIAL AND PLANT PROTECTION | BAYER AG (DE) | 1999-05-19 | — | — | EP | disclosed |
| EP-0865436-A1 | DITHIAZOLDIOXIDES AND THE USE THEREOF AS MICROBICIDES | BAYER AG (DE) | 1998-09-23 | — | — | EP | disclosed |
| WO-1998004562-A1 | PYRAZINE DERIVATIVES AND THEIR USE FOR MATERIAL AND PLANT PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 1998-02-05 | — | — | WO | disclosed |
| WO-1997020830-A1 | DITHIAZOLDIOXIDES AND THE USE THEREOF AS MICROBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-06-12 | — | — | WO | disclosed |
| EP-0750542-A1 | COMBINATIONS OF ACTIVE INSECTICIDE SUBSTANCES | BAYER AG (DE) | 1997-01-02 | — | — | EP | disclosed |
| EP-0713485-A1 | THIOCARBAMOYL COMPOUNDS | BAYER AG (DE) | 1996-05-29 | — | — | EP | disclosed |
| EP-0705160-A1 | FUNGICIDAL ACTIVE-SUBSTANCE COMBINATION | BAYER AG (DE) | 1996-04-10 | — | — | EP | disclosed |
| WO-1995024997-A1 | COMBINATIONS OF ACTIVE INSECTICIDE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-09-21 | — | — | WO | disclosed |
| WO-1995004722-A1 | THIOCARBAMOYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1995-02-16 | — | — | WO | disclosed |
| WO-1995000303-A1 | FUNGICIDAL ACTIVE-SUBSTANCE COMBINATION | BAYER AKTIENGESELLSCHAFT (DE) | 1995-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11185074-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | IFNG, TLR1, IDO1 | L3MBTL1 1835/4885TDP1 916/4885KDM4E 1828/4885 |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | CYP1B1, CYP51A1, CYP1A1 | L3MBTL1 1661/4885TDP1 1162/4885KDM4E 852/4885 |
| US-20130324457-A1 | 1-ARYL-5-ALKYL PYRAZOLE DERIVATIVE COMPOUNDS, PROCESSES OF MAKING AND METHODS OF USING THEREOF | CBR3, CBR1, NR5A2 | L3MBTL1 1034/4885TDP1 3985/4885KDM4E 3120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.